Evidence, Access and the People Who Decide
Practical writing on real-world evidence, HEOR and market access: which meetings matter, who is in the room, and how evidence turns into a decision.
Everything We Have Published
Top 10 RWE, HEOR & Market Access Conferences for Pharma Professionals in 2026
The relationship between real-world evidence, health economics, and market access has tightened. Payers want outcomes data. HTA bodies are embedding RWE into joint assessments. Regulators are expanding guidance on what counts as credible real-world data. For pharma professionals working across these functions, staying current is no longer enough, the work requires active engagement with how standards, methods, and policy expectations are shifting in real time.
10 Leading Pharma Events for Real-World Data, Analytics & Evidence Generation in 2026
Real-world data is only as valuable as what you do with it. The challenge in 2026 is no longer data scarcity, it is knowing how to access the right data sources, apply rigorous analytical methods, meet regulatory standards, and translate findings into decisions that move products forward.
Companies and Decision-Makers You Can Meet at RWE Connect 2026
Most conferences introduce you to people. The right conferences introduce you to the right people: those with the authority to evaluate a partnership, make a data decision, or move a market access strategy forward.
RWE Connect Sponsorship Guide: Benefits, Audience & ROI
Sponsoring a conference is a commercial decision. The question is not whether a conference has an audience. It is whether that audience includes people who can actually move a business decision forward.
Read It, Then Be in the Room
The people these articles are about will be on stage in London on 13 to 14 April 2027.